| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 1081-73-8 | 1-(2-(4-溴苯氧基)乙基)吡咯烷; 1-(4-溴苯氧基)-2-(1-吡咯烷基)乙烷 | N-[2-(4-Bromophenoxy)ethyl]pyrrolidine; 4-[2-Pyrrolidinoethoxy]phenyl bromide |  | C12H16BrNO | 詳情 | 供應(yīng)商 |
| 30707-77-8 | 1-(4-氨基苯基)-3-(1-吡咯烷基)-5-吡唑酮 | 1-(4-Aminophenyl)-3-(1-pyrrolidino)-5-pyrazolone; 2-(4-Aminophenyl)-5-pyrrolidin-1-yl-4H-pyrazol-3-one; 2-(4-Aminophenyl)-2,4-dihydro-5-(1-pyrrolidinyl)-3H-pyrazol-3-one |  | C13H16N4O | 詳情 | 供應(yīng)商 |
| 30818-17-8 | 1-(4-硝基苯基)-3-(1-吡咯烷基)-5-吡唑酮 | 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one; 2-Pyrazolin-5-one,1-(p-nitrophenyl)-3-(1-pyrrolidinyl)- (8CI); 1-(4-Nitrophenyl)-3-pyrrolidino-2-pyrazolin-5-one; 1-(p-Nitrophenyl)-3-pyrrolidino-5-pyrazolone |  | C13H14N4O3 | 詳情 | 供應(yīng)商 |
| 119302-19-1 | (2a,3a,5a,16b,17b)-2,3-環(huán)氧-16-(1-吡咯烷基)雄甾烷-17-醇 | 2a,3a-Epoxy-16b-(1-pyrrolidinyl)-5a-androstan-17b-ol; (2a,3a,5a,16b,17b)-2,3-Epoxy-16-(1-pyrrolidinyl)androstan-17-ol |  | C23H37NO2 | 詳情 | 供應(yīng)商 |
| 119302-20-4 | (2b,3a,5a,16b,17b)-2-(4-嗎啉基)-16-(1-吡咯烷基)雄甾烷-3,17-二醇 | (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol |  | C27H46N2O3 | 詳情 | 供應(yīng)商 |
| 119302-24-8 | (2b,3a,5a,16b,17b)-17-乙酰氧基-3-羥基-2-(4-嗎啉基)-16-(1-吡咯烷基)雄甾烷 | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane; (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol 17-acetate |  | C29H48N2O4 | 詳情 | 供應(yīng)商 |
| 135540-11-3 | 1-(氯-1-吡咯烷基亞甲基)吡咯烷鎓六氟磷酸鹽 | 1-(Chloro-1-pyrrolidinylmethylene)pyrrolidinium hexafluorophosphate |  | C9H16ClF6N2P | 詳情 | 供應(yīng)商 |
| 156311-83-0 | (3H-1,2,3-三唑并[4,5-b]吡啶-3-氧基)三-1-吡咯烷基鏻六氟磷酸鹽 | (3-Hydroxy-3H-1,2,3-triazolo[4,5-b]pyridinato-O)tri-1-pyrrolidinylphosphonium hexafluorophosphate |  | C17H27N7OP.PF6 | 詳情 | 供應(yīng)商 |
| 687603-66-3 | 1-(1,3-苯并二氧雜環(huán)戊-5-基)-2-(1-吡咯烷基)-1-戊酮 | 1-(1,3-Benzodioxol-5-yl)-2-(1-pyrrolidinyl)-1-pentanone; 1-(3,4-Methylenedioxyphenyl)-2-pyrrolidinylpentan-1-one |  | C16H21NO3 | 詳情 | 供應(yīng)商 |
| 64347-09-7 | 1-[2-[[2-[[2-[[2-[2,5-二氧-3-二十四烯基-1-吡咯烷基]乙基]氨基]乙基]氨基]乙基]氨基]乙基]-3-十八烯基-2, | 5-Pyrrolidinedione, 1-[2-[[2-[[2-[[2-[2,5-dioxo-3-(tetracosenyl)-1-pyrrolidinyl]ethyl]amino]ethyl] a; 1-[2-[[2-[[2-[[2-[2,5-dioxo-3-(tetracosenyl)-1-pyrrolidin yl]ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-3-(octadecenyl)- 2,5-Pyrrolidinedione |  | C58H107N5O4 | 詳情 | 供應(yīng)商 |
| 64051-48-5 | 1-[2-[[2-[[2-[[2-[3-(二十烯基)-2,5-二氧-1-吡咯烷基]乙基]氨基]乙基]氨基]乙基]氨基]乙基]-3-十八烯基-2, | Octadecenylsuccinic, eicosenylsuccinic tetraethylenepentamine diimide 2,5-Pyrrolidinedione,1-[2-[[2- |  | C54H99N5O4 | 詳情 | 供應(yīng)商 |
| 64347-13-3 | 1-[2-[[2-[[2-[[2-[3-(二十二烯基)-2,5-二氧-1-吡咯烷基]乙基]氨基]乙基]氨基]乙基]氨基]乙基]-3-二十烯基- | 5-Pyrrolidinedione, 1-[2-[[2-[[2-[[2-[3-(docosenyl)-2,5-dioxo-1-pyrrolidinyl]ethyl]amino]ethyl]amino; 2,5-Pyrrolidinedione,1-[2-[[2-[[2-[[2-[3-(docosenyl)-2,5-dioxo-1-pyrrolidinyl]ethyl]amino]ethyl]amino]ethyl]amino]ethyl]-3-(eicosenyl)-(9CI) |  | C58H107N5O4 | 詳情 | 供應(yīng)商 |
| 64051-46-3 | 1-[2-[[2-[[2-[[2-[3-二十二烯基-2,5-二氧-1-吡咯烷基]乙基]氨基]乙基]氨基]乙基]氨基]乙基]-3-十八烯基-2, | 5-Pyrrolidinedione, 1-[2-[[2-[[2-[[2-[3-(docosenyl)-2,5-dioxo-1-pyrrolidinyl]ethyl]amino]ethyl] amin |  | C56H103N5O4 | 詳情 | 供應(yīng)商 |
| 64051-44-1 | 1-[2-[[2-[[2-[[2[3-(二十烯基)-2,5-二氧代-1-吡咯烷基]乙基]氨基]乙基]氨基]乙基]氨基]乙基]-3-二十四烯基 | 5-Pyrrolidinedione, 1-[2-[[2-[[2-[[2-[3-(eicosenyl)-2,5-dioxo-1-pyrrolidinyl]ethyl]amino]ethyl] amin |  | C60H111N5O4 | 詳情 | 供應(yīng)商 |
| 127641-25-2 | (1R,2S)-1-苯基-2-(1-吡咯烷基)-1-丙醇 | 1-Pyrrolidineethanol, b-methyl-a-phenyl-, (aR,bS)-; 1-Pyrrolidineethanol,b-methyl-a-phenyl-, [R-(R*,S*)]-; (1R,2S)-2-Pyrrolidino-1-phenyl-1-propanol; (aR,bS)-b-Methyl-a-phenyl-1-pyrrolidineethanol |  | C13H19NO | 詳情 | 供應(yīng)商 |
| 19213-23-1 | (1-吡咯烷基甲基)苯并三唑 | 1H-Benzotriazole,1-(1-pyrrolidinylmethyl)-; (1-PYRROLIDINYLMETHYL)BENZOTRIAZOLE 97&; (1-PYRROLIDINYLMETHYL)BENZOTRIAZOLE, 97% , MIXTURE OF BT1 AND BT2 ISOMERS; (1-pyrrolidinylmethyl)benzotriazole, mixture of bt1 and bt2 isomers |  | C11H14N4 | 詳情 | 供應(yīng)商 |
| 96744-75-1 | (+)-(5Α,7Α,8Β)-N-甲基-N-[7-(1-吡咯烷基)-1-氧螺[4.5]十二-8-基]-苯乙酰胺 | U-69593; U-69593; (+)-(5ALPHA,7ALPHA,8BETA)-N-METHYL-N-[7-(1-PYRROLIDINYL)-1-OXASPIRO[4.5]DEC-8-YL]-BENZENEACETAMIDE; (5ALPHA,7ALPHA,8BETA)-(+)-N-METHYL-N-(7-[1-PYRROLIDINYL]-1-OXASPIRO[4.5]DEC-8-YL)-BENZENEACETAMIDE; U-69593 SELECTIVE K OPIOID AG; (5A,7A,8B)-(-)-N-METHYL-(7-(1-PYRROLIDINYL)-1-OXASPIRO (4.5)DEC-8- YL)BENZENEACETAMIDE); U69593, (+)-(5α,7α,8β)-N-Methyl-N-[7-(1-pyrrolidinyl)-1-oxaspiro[4.5]dec-8-yl]-benzeneacetamide; Benzeneacetamide, N-methyl-N-((5R,7S,8S)-7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-; Benzeneacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-, (5alpha,7alpha,8beta)-(-)- |  | C22H32N2O2 | 詳情 | 供應(yīng)商 |
| 17360-35-9 | 1-(4-[1-吡咯烷基]-2-丁炔基)-2-吡咯烷酮 | OXOTREMORINE SESQUIFUMARATE; 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinon(e)-2-butenedioate(2:3); 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonfumarate(2:3); 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonsesquifumarate; 1-(n-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinonesesquifumarate; oxotremorinefumarate(2:3); 1-[4-(1-PYRROLIDINYL)-2-BUTYNYL]-2-PYRROLIDINONE SESQUIFUMARATE; (1-[4-(1-PYRROLIDINYL)-2-BUTYNYL]-2-PYRROLIDINONE) SESQUIFUMARATE SALT; OXOTREMORINE SESQUIFUMARATE |  | C36H48N4O14 | 詳情 | 供應(yīng)商 |
| 210558-66-0 | (1S,2R)-1-苯基-2-(1-吡咯烷基)-1-丙醇鹽酸鹽; (1S,2R)-1-苯基-2-(1-吡咯烷基)-1-丙醇鹽酸鹽 | (IR,2S)-N-Pyrrolidinyl norephedrine HCL; (IR,2S)-N-Pyrrolidinyl norephedrine HCL; (1R,2S)-1-Phenyl-2-(1-pyrrolidinyl)propan-1-ol hydrochloride | 無 | 詳情 | 供應(yīng)商 | |
| 1234703-40-2 | (1R,2S)-2-環(huán)己基-1-[4-(環(huán)丙基磺�；�)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]環(huán)丙烷甲酰胺; (1R,2S)-2-環(huán)己基-1-[4-(環(huán)丙基磺�；�)苯基]-N-[5-[[2-(1-吡咯烷基)乙基]硫代]-2-噻唑基]環(huán)丙烷甲酰胺 | LY-2608204; LY-2608204; (1R,2S)-2-Cyclohexyl-1-[4-(cyclopropylsulfonyl)phenyl]-N-[5-[[2-(1-pyrrolidinyl)ethyl]thio]-2-thiazolyl]cyclopropanecarboxamide; (1R,2S)-2-cyclohexyl-1-(4-(cyclopropylsulfonyl)phenyl)-N-(5-((2-(pyrrolidin-1-yl)ethyl)thio)thiazol-2-yl)cyclopropanecarboxaMide | 無 | C28H37N3O3S3 | 詳情 | 供應(yīng)商 |